Home / Stocks / NAUT

NAUT insider trading

Nautilus Biotechnology, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$317k
Buys · last 90 days
0 · $0
Most recent buy
2026-03-04

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-04AH Bio Fund II, L.P.
10% owner
Sold4,615,974$2.35$10.8M
2026-03-04Patel Sujal M
CEO, President, and Secretary
Bought25,000$2.61$65k
2025-11-10Suzuki Kentaro
Chief Marketing Officer
Bought4,000$1.49$6k
2025-09-09Patel Sujal M
CEO, President, and Secretary
Bought200,000$0.67$135k
2025-09-05Murphy Matthew B.
General Counsel
Bought20,000$0.64$13k
2025-06-02Mowry Anna
CFO and Treasurer
Bought15,000$0.77$12k
2025-05-12Mallick Parag
Chief Scientist
Bought13,500$0.73$10k
2025-03-21Patel Sujal M
CEO, President, and Secretary
Bought77,233$0.99$77k

Most active insider buyers

InsiderRoleBuysTotal bought
Patel Sujal MCEO, President, and Secretary3$277k
Murphy Matthew B.General Counsel1$13k
Mowry AnnaCFO and Treasurer1$12k
Mallick ParagChief Scientist1$10k
Suzuki KentaroChief Marketing Officer1$6k

See NAUT on the chart

Every insider buy and sell for NAUT plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.